Managing the Adverse Effects of Interferon-?? Therapy in Multiple Sclerosis
- 1 January 2000
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 22 (2), 149-159
- https://doi.org/10.2165/00002018-200022020-00006
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon β-1b injectionsJournal of the American Academy of Dermatology, 1998
- Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosisMultiple Sclerosis Journal, 1998
- Interferon beta-1b injection site reactions and necrosesMultiple Sclerosis Journal, 1998
- A case of cutaneous necrosis during interferon-beta 1b (B-IFN) therapy in multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosisJournal of the American Academy of Dermatology, 1996
- Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosisJournal of Neuroimmunology, 1996
- An Open-Labelled Assessment of Adverse Effects Associated with Interferon 1-Beta in the Treatment of Multiple SclerosisJournal of Neuroscience Nursing, 1995
- Suicide and multiple sclerosis: an epidemiological investigation.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERONThe Lancet, 1987
- The Role of Liver in the Catabolism of Human - and beta-InterferonJournal of General Virology, 1982